JAMA Neurology (journal)

July 17, 2023

Alzheimer’s genetic risk tracked across sex, race

A Vanderbilt study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants ages 60 and older to elaborate these risks across sex and across the intersection of sex and race.

By Paul Govern
October 3, 2022

Minority patients less likely to have amyloid plaques necessary for Alzheimer’s treatments

Fewer Black, Hispanic and Asian patients meet biomarker qualifications for landmark treatments that may slow the progression of Alzheimer’s disease by targeting amyloid plaques, according to new findings published in JAMA Neurology.

By Holly Fletcher
November 4, 2019

Sleep experts: daylight saving time has long-term brain effects

Sleep experts published a JAMA Neurology commentary in which they recap large epidemiological studies to advocate for ending the practice.

By VUMC News and Communications
May 7, 2018

Study provides robust evidence of sex differences with Alzheimer’s gene

The APOE gene, the strongest genetic risk factor for Alzheimer’s disease, may play a more prominent role in disease development among women than men, according to new research from the Vanderbilt Memory and Alzheimer’s Center.

By Tom Wilemon
hospitalized African American child
May 26, 2016

Study links hyperglycemia in pediatric stroke patients to poor outcomes

Childhood stroke patients with hyperglycemia may be more at risk for disability, according to a Vanderbilt University Medical Center (VUMC) study that sought to determine if vital sign measurements and blood glucose levels could be associated with poor neurological outcomes.

By Tom Wilemon